Johnson & Johnson's coronavirus vaccine is fourth to begin Phase 3 trials in the United States
Initial findings from the vaccine's Phase 1/2 trials in the United States and Belgium suggest that a single dose of the vaccine provokes an immune response and is safe enough to mo…
